Variation in survival for adults with nasopharyngeal cancer in Europe, 1978-1989

European Journal of Cancer

Volumn 34, Issue 14, 1998, Pages 2162-2166

  Jiong, Li ^a,b   Berrino, F ^c,ay   Coebergh, J W W ^a,d,at   Oberaigner, W ^e   Storm, H ^f   Aareleid, T ^g   Hakulinen, T ^h   Pottier, D ⁱ   Mace Lesec'H, J ^j   Faivre, J ^k   Arveux, P ^l   Esteve J ^m   Raverdy, N ⁿ   Ziegler, H ^o   Tryggvadottir, L ^p   Tulinius, H ^p   Crosignani, P ^p   Gatta, G ^p   Micheli, A ^q   Sant, M ^q   Conti, E ^r   Vercelli, M ^s   Federico, M ^t   Mangone, L ^u   Ponz De Leon, M ^v   De Lisi, V ^w   Zanetti, R ^x   Gafa L ^y   Tumino, R ^z   Falcini, F ^aa   Barchielli, A ^ab   Capocaccia, R ^ac   De Angelis, G ^ad   Valente, F ^ae   Verdecchia, A ^af   Pawlega, J ^ag   Rachtan, J ^af   Bielska Lasota, M ^ag   Wronkowski, Z ^ag   Obsitnikova, A ^ah   Plesko, I ^ai   Pompe Kirn, V ^aj   Izarzugaza, I ^ak   Garau, I ^al   Ardanaz, E ^am   Moreno, C ^an   Galceran, J ^ao   Moller T ^ap   Torhorst, J ^aq   Bouchardy, C ^ar   Raymond, L ^as   Damhuis, R A M ^au   Gould, A ^av   Black, R J ^aw   Davies, T W ^ax   Stockton, D ^ax   Coleman, M P ^av   Williams, E M I ^aw   Littler, J ^at   Forman, D ^ax   Quinn, M J ^ax   Roche, M ^ax   Smith, J ^ar   Bell, J ^as   Lawrence, G ^at   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b FUDAN UNIVERSITY   (China)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d EindhovenCancer Registry   (Netherlands)

^e Cancer Registry of Tirol   (Denmark)

^f DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^g Estonian Cancer Registry   (Finland)

^h Finnish Cancer Registry   (France)

ⁱ Calvados Digestive Cancer Registry   (France)

^j Calvados General Cancer Registry   (France)

^k Côte d' or Digestive Cancer Registry   (France)

^l Doubs Cancer Registry   (France)

^m INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

ⁿ Somme Cancer Registry   (Germany)

^o Saarland Cancer Registry   (Iceland)

^p Icelandic Cancer Registry   (Italy)

^q Lombardy Cancer Registry   (Italy)

^r Latina Cancer Registry   (Italy)

^s Liguria Cancer Registry   (Italy)

^t MODENA CANCER REGISTRY   (Italy)

^u Modena Colorectal Cancer Registry ^*  (Italy)

^v PARMA CANCER REGISTRY   (Italy)

^w Center for Epidemiology and Prevention in Oncology   (Italy)

^x Ragusa Cancer Registry   (Italy)

^y Romagna Cancer Registry   (Italy)

^z Tuscan Cancer Registry   (Italy)

^aa ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^ab Cracow Cancer Registry   (Poland)

^ac INSTITUTE OF ONCOLOGY   (Poland)

^ad National Cancer Registry of   (Slovakia)

^ae INSTITUTE OF ONCOLOGY   (Slovenia)

^af Departamento de Sanidad Gobierno Vasco   (Spain)

^ag Mallorca Cancer Registry   (Spain)

^ah Navarra Cancer Registry   (Spain)

^ai Tarragona Cancer Registry   (Spain)

^aj Southern Swedish Regional Tumour Registry   (Sweden)

^ak Cancer Registry of Basel   (Switzerland)

^al GENEVA CANCER REGISTRY   (Switzerland)

^am Eindhoven Cancer Registry   (Netherlands)

^an Integraal Kankercentrum Rotterdam   (Netherlands)

^ao Scottish Cancer Registry   (United Kingdom)

^ap East Anglian Cancer Registry   (United Kingdom)

^aq LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^ar Merseyside and Cheshire Cancer Registry   (United Kingdom)

^as Northern and Yorkshire Cancer Registry and Information Service   (United Kingdom)

^at OYce for National Statistics   (United Kingdom)

^au UNIVERSITY OF OXFORD   (United Kingdom)

^av S and West Cancer Intelligence Unit   (United Kingdom)

^aw Thames Cancer Registry   (United Kingdom)

^ax W Midlands Cancer Intelligence Unit   (United Kingdom)

^ay NONE

more..

Author keywords

Adults; Europe; Histiotype; Nasopharyngeal carcinoma; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; EUROPE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CANCER; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; UNDIFFERENTIATED CARCINOMA;

EID: 0032413681     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00322-0     Document Type: Article

References (20)

1. Ferlay J, Blackers SL, Whelan SL, Parkin DM, eds. Cancer Incidence in Five Continents. Volume VII. Lyon, IARC Scientific Publications No. 143. Lyon, International Agency for Research on Cancer, 1997.
2. Wang D.C., Cai W.M., Hu Y.H., Gu X.Z. Long term survival of 1035 cases of nasopharyngeal carcinoma. Cancer. 61:1988;2338-2341.
3. Payne D.G. Carcinoma of the nasopharynx. J Otolaryngol. 12:1983;197-202.
4. Chatani M., Matayoshi Y., Masak N., Fujii T. Treatment results and prognostic factors for nasopharyngeal cancer. Strahlen Ther Onkol. 169:1993;527-533.
5. Shanmugaratnam K, Chan SH, de-The G, et al. Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics. Cancer 1979, 43, 1029-1044.
6. Levine P.H., Connelly R.R., Eastern J.M. Demographic patterns for nasopharyngeal carcinoma in the United States. Int J Cancer. 26:1980;741-748.
7. Burt R.D., Vaughan T.L., McKnight B. Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States. Int J Cancer. 52:1992;549-556.
8. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, and Esteve J, eds. Survival of cancer patients in Europe: the EUROCARE study. IARC Scientific Publications No 132. Lyon, International Agency for Research on Cancer, 1995.
9. Berrino F., Gatta G., Chessa E., Valente F., Capocaccia R. Introduction: The EUROCARE II study. Eur J Cancer. 34:1998;2139-2153.
10. European Network of Cancer Registries. EUROCIM User Manual, 3rd Edition, Lyon, International Agency for Research on Cancer, 1998.
11. Hakulinen T., Abeywickrama K.J. Computer program package for relative survival rates. Comp Prog Biomed. 19:1985;197-207.
12. Greenwood M. Reports on Public Health and Medical Subjects No. 33., Appendix 1: the errors of sampling of the survivorship tables. Her Majesty's Stationery Office, 1926.
13. Cox D.R. Regression models and life tables (with discussion). J R Stat Soc. 34:1972;187-220.
14. Papavasiliou C., Pavlatou M., Pappas J. Nasopharyngeal cancer in patients under the age of thirty years. Cancer. 40:1977;2312-2316.
15. Levine P.H., Mckay F.W., Connelly R.R. Patterns of nasopharyngeal cancer mortality in the United States. Int J Cancer. 34:1987;133-137.
16. Qin D, Yuhua H, Jiehua Y, et al. Analysis of 1379 patients with nasopharyngeal carcinoma: correlations with epidemiology, survival and other biological characteristics. Cancer 1988, 61, 1117-1124.
17. Zhang EP, Lian PG, Cai KL, et al. Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1320 patients. Int J Radiat Oncol Biol Phys 1989, 16, 301-305.
18. Pendier I., Krejovic B., Vucicevic S. A comparative study of undifferentiated nasopharyngeal carcinoma treated with radiotherapy or combined treatment with zorubicin-cisplatin and radiotherapy. Eur Arch Otorhinolaryngol. 1:(Suppl.):1997;127-129.
19. Altun M., Fandi A., Supuis O., Cvitokovic E., Krajina Z., Eschwege F. Undifferentiated nasopharyngeal cancer: current diagnostic and therapeutic aspects. Int J Radiat Oncol Biol Phys. 32:1995;859-877.
20. Koukourakis M.I., Whitehouse R.M., Giatromanolaki A., Saunders M., Kaklamanis L. Predicting distant failure in nasopharyngeal cancer. Laryngoscope. 106:1996;765-771.